E9-Rate of Macular Atrophy in HARBOR Study- Dr. SriniVas Sadda
The Retina Channel Podcast03/12/18 • 15 min
Dr. SriniVas Sadda discusses development of macular atrophy in an analysis of HARBOR Study which investigated treatment of wet AMD using 0.5 mg and 2.0 mg of Ranibizumab dosing.
Full reference of the discussed article:
Sadda, S. R., Tuomi, L. L., Ding, B., Fung, A. E., & Hopkins, J. J. (2018). Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration. Ophthalmology. doi:10.1016/j.ophtha.2017.12.026
03/12/18 • 15 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-retina-channel-podcast-386218/e9-rate-of-macular-atrophy-in-harbor-study-dr-srinivas-sadda-54935166"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to e9-rate of macular atrophy in harbor study- dr. srinivas sadda on goodpods" style="width: 225px" /> </a>
Copy